Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Ipsen Biopharmaceuticals, Inc.

Oncology Briefings™: Updates in the Treatment of GEP-NETs

Release Date: December 13, 2021
Expiration Date: December 13, 2022

Activity Overview

This online activity is designed to provide a concise and focused overview on the management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including current diagnosis, evaluation, treatment, and supportive care options. The engaging, multimedia format of this program includes audio commentary from an expert thought leader integrated into text-based elements.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Ipsen Biopharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

Complete the activity (including pre- and post-activity assessments).
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward oncologists, gastroenterologists, and pathologists involved in the treatment of GEP-NETs. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals (HCPs) involved in the treatment of GEP-NETs are also invited to participate in this activity.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Explain the clinical presentation, distinguishing characteristics, classification, and staging of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Delineate various testing methodologies for diagnosis as well as monitoring of treatment for GEP-NETs
Discuss evolving therapeutic approaches for patients with GEP-NETs based on recent clinical trial data and evidence-based guidelines

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

Faculty

Diane Reidy-Lagunes, MD, MS
Associate Deputy Physician-in-Chief, Regional Care Network
Associate Attending
Memorial Sloan Kettering Cancer Center
Associate Professor of Clinical Medicine
Cornell Weill Medical College
New York, NY

Disclosures: Grant/Research Support: Merck, Ipsen, Novartis; Consultant: Novartis, Advanced Accelerator Applications, Bind, Chiasma, ITM, Akita Biomedical.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.